title: What is the potential of epigenetics in drug development?
authors.forename: Kenneth
authors.initials: K
authors.lastname: Lundstrom
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002626:Chemistry, Pharmaceutical; D002986:Clinical Trials as Topic; D004247:DNA / Q000187:drug effects* / Q000235:genetics; D019175:DNA Methylation / Q000187:drug effects* / Q000235:genetics; D017277:Drug Approval; D055808:Drug Discovery; D044127:Epigenesis, Genetic / Q000187:drug effects*; D056572:Histone Deacetylase Inhibitors / Q000494:pharmacology*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D056572:Histone Deacetylase Inhibitors; D004247:DNA
keywords: DNA methylation; RNA interference; drug development; epigenetics; histone modifications; micro-RNA